Literature DB >> 18523503

Confirmation of needle placement within the piriformis muscle of a cadaveric specimen using anatomic landmarks and fluoroscopic guidance.

Peter Gonzalez1, Michelle Pepper, William Sullivan, Venu Akuthota.   

Abstract

Of patients presenting to pain clinics, complaints are of low back or buttock pain with or without radicular leg symptoms is one of the most common. Piriformis syndrome may be a contributor in up to 8% of these patients. The mainstay of treatment is conservative management with physical therapy, anti-inflammatory medications, muscle relaxants, and correction of biomechanical abnormalities. However, in recalcitrant cases, a piriformis injection of anesthetic and/or corticosteroids may be considered. Because of its small size, proximity to neurovascular structures, and deep location, the piriformis muscle is often injected with the use of commuted tomography (CT), magnetic resonance imaging (MRI), ultrasound (US), fluoroscopy, electrical stimulators, or electromyography (EMG). Numerous techniques have been proposed using one or a combination of the above modalities. However, application of these techniques is limited by unavailability of CT, MRI, and EMG equipment as well as a paucity of trained physicians in US-guided procedures in many pain treatment centers throughout the United States. Fluoroscopy, however, is more widely available in this setting. This study utilized a cadaveric specimen to confirm proper needle placement for piriformis or peri-sciatic injection utilizing the previously documented landmarks for fluoroscopic guidance as described by Betts. An anteroposterior of the pelvis with inclusion of the acetabular region of the hip and the inferior aspect of the sacroiliac joint was obtained. The most superior-lateral aspect of the acetabulum and the inferior aspect of the sacroiliac joint were identified. A marker was placed one-third of the distance from the acetabular location to the inferior sacroiliac joint, indicating the target location. A 22-gauge, 3.5-inch spinal needle was directed through the gluteal muscles to the target location using intermittent fluoroscopic guidance. The posterior ileum was contacted and the needle was withdrawn 1 -2 mm. This approach found the needle within the piriformis muscle belly 2 -3 cm lateral to sciatic nerve. The present study was the first study, to our knowledge, that has confirmed the intramuscular position of the needle within the piriformis muscle of a cadaveric specimen using these anatomic landmarks and fluoroscopic guidance.

Entities:  

Mesh:

Year:  2008        PMID: 18523503

Source DB:  PubMed          Journal:  Pain Physician        ISSN: 1533-3159            Impact factor:   4.965


  5 in total

Review 1.  Piriformis syndrome: a case series of 31 Bangladeshi people with literature review.

Authors:  Md Abu Bakar Siddiq; Md Shawkat Hossain; Mohammad Moin Uddin; Israt Jahan; Moshiur Rahman Khasru; Neaz Mahmud Haider; Johannes J Rasker
Journal:  Eur J Orthop Surg Traumatol       Date:  2016-09-19

2.  Use of botulinum neurotoxin in the treatment of piriformis syndrome: A systematic review.

Authors:  Minghe Moses Koh; Yeow Leng Tan
Journal:  J Clin Orthop Trauma       Date:  2022-07-09

3.  Interventional pain management in rheumatological diseases - a three years physiatric experience in a tertiary medical college hospital in bangladesh.

Authors:  Md Abu Bakar Siddiq; Suzon Al Hasan; Gautam Das; Amin Uddin A Khan
Journal:  Korean J Pain       Date:  2011-11-30

4.  Piriformis syndrome in fibromyalgia: clinical diagnosis and successful treatment.

Authors:  Md Abu Bakar Siddiq; Moshiur Rahman Khasru; Johannes J Rasker
Journal:  Case Rep Rheumatol       Date:  2014-09-22

Review 5.  Ultrasound-Guided Injection of Botulinum Toxin Type A for Piriformis Muscle Syndrome: A Case Report and Review of the Literature.

Authors:  Andrea Santamato; Maria Francesca Micello; Giovanni Valeno; Raffaele Beatrice; Nicoletta Cinone; Alessio Baricich; Alessandro Picelli; Francesco Panza; Giancarlo Logroscino; Pietro Fiore; Maurizio Ranieri
Journal:  Toxins (Basel)       Date:  2015-08-10       Impact factor: 4.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.